A simple and rapid assay to evaluate purity of foot-and-mouth disease vaccine before animal experimentation
Abstract
No abstract availableKeywords
Funding Information
- Animal and Plant Quarantine Agency
This publication has 17 references indexed in Scilit:
- Comparative evaluation of non-structural protein-antibody detecting ELISAs for foot-and-mouth disease sero-surveillance under intensive vaccinationJournal of Virological Methods, 2014
- Development and validation of a 3ABC antibody ELISA in Australia for foot and mouth diseaseAustralian Veterinary Journal, 2014
- Time will tell: community acceptability of HIV vaccine research before and after the “Step Study” vaccine discontinuationOpen Access Journal of Clinical Trials, 2010
- Domain disruptions of individual 3B proteins of foot-and-mouth disease virus do not alter growth in cell culture or virulence in cattleVirology, 2010
- Development of an in process control filtration-assisted chemiluminometric immunoassay to quantify foot and mouth disease virus (FMDV) non-capsid proteins in vaccine-antigen batchesVaccine, 2010
- Updating of the correlation between lpELISA titers and protection from virus challenge for the assessment of the potency of polyvalent aphtovirus vaccines in ArgentinaVaccine, 2008
- Development of an epitope-blocking-enzyme-linked immunosorbent assay to differentiate between animals infected with and vaccinated against foot-and-mouth disease virusJournal of Virological Methods, 2007
- Differential distribution of non-structural proteins of foot-and-mouth disease virus in BHK-21 cellsVirology, 2006
- Foot-and-Mouth DiseaseClinical Microbiology Reviews, 2004
- Genome-linked protein VPg of poliovirus is present as free VPg and VPg-pUpU in poliovirus-infected cells.Proceedings of the National Academy of Sciences, 1983